Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

In this episode, D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, answer questions on investigational antibody-drug conjugates for advanced NSCLC  

Presenters:

Ross Camidge, MD, PhD  
Professor of Medicine/Oncology  
University of Colorado Cancer Center
Aurora, Colorado

Joel W. Neal, MD, PhD  
Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

Content based on an online IME program supported by educational grants from Daiichi Sankyo, Inc .

Link to full program:
http://bit.ly/3twpIyl

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.